Search results
Results from the WOW.Com Content Network
This page was last edited on 16 February 2024, at 22:50 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
C. Calico (company) Caliper Life Sciences; Calyx (clinical research company) Cambrian Genomics; Cannabis Science; Catalent; Catalyst Pharmaceuticals; CD Genomics
New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. [2] It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. [3]
[citation needed] Only a sugar-cube-sized sample of the tumor is needed for subsequent presentation to the dendritic cells. The tumor sample is first broken down into constituent proteins using a caustic process known as lysing (thus the L in the name DCVax-L). After the resulting "tumor lysate" is presented to the dendritic cells, they are ...
This is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index contains 401 stocks because it includes two share classes of stock from 1 of its ...
Crown Bioscience is a company that offers a range of preclinical and translational drug research and development platforms and services. These include in vivo, in vitro, ex vivo patient derived xenograft (PDX), cell line derived xenograft (CDX), organoids and 3D models, as well as oncology databases, biomarker, bioanalysis and bioinformatics services.
Chairman and CEO of Paragon Biosciences, LLC Jeff Aronin (born December 8, 1967) is an American investor, entrepreneur, and biotechnology executive. He is founder, chairman and CEO of Paragon Biosciences, LLC, a global life science company that creates, builds, and funds innovative biology-based companies.
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.